ADVENZYMESAdvanced Enzyme Technologies Ltd
Advanced Enzyme Technologies buys back 49,647 shares on 15 Oct, taking its total past 20 lakh
- Corporate action
Advanced Enzyme Technologies Limited has filed its daily report for its open-market share buyback for 15 Oct 2026. On that day it bought back 49,647 equity shares of face value ₹2 each, all on NSE, through Emkay Global Financial Services Limited, at an average price of ₹269.0964 per share, excluding transaction costs.
The company had bought back 19,53,660 shares up to the previous day, so the total bought back as of 15 Oct 2026 is 20,03,307 shares. The report shows no quantity closed out, and is filed under Regulation 18(i) of the SEBI Buy-Back of Securities Regulations, 2018.
Inference
A buyback reduces the number of shares in the market, so each remaining share represents a slightly larger part of the company. With 20,03,307 shares bought so far, the report is a running count, and it does not state the total size of the programme.
The average price of ₹269.0964 on 15 Oct 2026 is higher than the ₹266.8579 average the company reported for 13 Oct 2026. Shareholders can follow the later daily reports to see how the programme progresses.
Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
